NCT00215046View on ClinicalTrials.gov

Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Intraluminal Pulmonary Vein Stenosis
Interventions
DRUG

Vinblastine

drug - dosage and frequency is based on size of patient and response to treatment.

DRUG

Methotrexate

drug - dosage is based on size of patient and frequency and duration is based on response to treatment.

Trial Locations (2)

02115

Children's Hospital Boston, Boston

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

lead

Boston Children's Hospital

OTHER

NCT00215046 - Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis | Biotech Hunter | Biotech Hunter